Reliance Industries-powered Strand Life Sciences unveils CancerSpot test for early detection of multiple cancers
Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer ...
Reliance subsidiary Strand Life Sciences’ blood-based test to detect multiple cancers early-on
Strand Life Sciences launches CancerSpot, a blood-based test for early cancer detection, using advanced methylation profiling ...
ThePrint9d
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering Blood-based Test for Early Detection of Multiple Cancers
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a ...
money.rediff11d
Strand Life Sciences Launches Blood Test for Early Cancer Detection
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling for early detection of multiple ...
The Financial Express9d
Reliance subsidiary Strand Life Sciences launches blood-based test for early detection of multiple cancers
Speaking at the opening of Strand’s new Genomics Diagnostics & Research Centre in Bengaluru, company CEO and Co-Founder Dr.
devdiscourse11d
Strand Life Sciences Launches Groundbreaking Cancer Detection Test
Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling technology for early detection of multiple cancers. The test aims to address the growing cancer burden in ...
AI helping in early cancer detection via genomics solutions, data analytics
Bengaluru-based Strand Life Sciences, a Reliance Industries subsidiary, has partnered with Agilent, Celemics, and SOPHiA ...
Genomic testing players like RIL's Strand eye tier-2, 3 markets as demand grows
Genomic testing involves analysing or sequencing a person’s DNA, to identify genetic changes that can help diagnose or screen ...
Webindia 1239d
Strand Life Sciences, a Reliance subsidiary, Launches Pioneering Blood-based Test for Early Detection of Multiple Cancers
Leading genomics and bioinformatics company Strand Life Sciences, a subsidiary of Reliance Industries Limited, has launched a novel blood-based test for early detection of multiple cancers.
Pharmabiz9d
Strand Life Sciences subsidiary of Reliance Life Sciences launches blood test for early detection of multiple cancers
Strand Life Sciences subsidiary of Reliance Life Sciences launches blood test for early detection of multiple cancers: Our Bureau, Bengaluru Monday, December 2, 2024, 14:40 Hrs [I ...